🔎 Trials Near Me

Akèy › Leukemi limfoblastik ak limfom selil T prekursè › Missouri › St. Louis

Etid klinik pou Leukemi limfoblastik ak limfom selil T prekursè nan St. Louis, MO

3 etid pou Leukemi limfoblastik ak limfom selil T prekursè ap chèche patisipan nan sit nan ak bò kote St. Louis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

Ap rekriteFaz 2
  • Washington University Saint Louis, St Louis
6 Months · Tout sèks · Mizajou Sep 28, 2026 · NCT06514794

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

Ap rekriteFaz 1
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at West County Hospital, Creve Coeur · 12 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT04301076

A Registry for People With T-cell Lymphoma

Ap rekriteEtid obsèvasyon
  • Washington University (Data Collection Only), St Louis
Tout laj · Tout sèks · Mizajou May 20, 2026 · NCT05978141

Etid Leukemi limfoblastik ak limfom selil T prekursè nan lòt vil

Lòt etid nan St. Louis

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.